Selected Publications 
Yang SC, Owen — Schaub L, Mendiguren — Rodriguez A, Grimm EA, Hong WK, Roth JA: 
Combination immunotherapy for non — small cell lung cancer: Results using interleukin — 2 
and tumor necrosis factor — a. J Thorac Cardiovasc Surg 99:8-13, 1990. 
Yang SC, Owen — Schaub LB, Roth JA, Grimm EA: Characterization of OKT3 — initiated 
lymphokine — activated effectors expanded with interleukin — 2 and tumor necrosis factor — oc. 
Cancer Res. 50(16):3526-3532, 1990. 
Putnam JB, Lammermeier DE, Colon R, McMurtrey MJ, Ali MK, Roth JA: Predicted 
pulmonary function and survival after pneumonectomy for primary lung carcinoma. Ann 
Thor Surg 49:909-915, 1990. 
Schneider PM, Hung M-C, Ames RS, Putnam EA, Akpakip B, Roth JA: A novel alteration in 
the epidermal growth factor receptor gene is frequently detected in human non-small cell 
lung cancer. Lung Cancer 6:65-72, 1990. 
EUerbroek NA, Fossella FV, Rich TA, Ajani JA, Komaki R, Roth JA, Holoye PY: Low- 
dose continuous infusion cisplatinum combined with external beam irradiation for advanced 
colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Inter J Radia 
Oncol, Biol, Phys 20(2): 35 1-355, 1991. 
Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA: Specific inhibition of K-ras expression 
and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res 51:1744-1748, 1991. 
Pass HI, Evans S, Matthews WA, Perry R, Venzon D, Roth JA, Smith P: Photodynamic 
therapy of oncogene-transformed cells. J Thorac Cardiovasc Surg 101:795-799, 1991. 
Yang SC, Grimm EA, Roth JA: Biologic therapy for lung cancer. The Cancer Bulletin 
43(2)100-108, 1991. 
Lazenby AW, Yang SC, Sniege N, Grimm EA, Roth JA: Regression of radiation and 
chemotherapy resistant non-small ceU lung cancer treated with OKT3, interleukin-2, and 
tumor necrosis factor. The Cancer Bulletin 43(2): 181-184, 1991. 
Slater ID, EUerbroek NA, Barkley HT, Mountain C, Oswald MJ, Roth JA, Peters U: 
Radiation therapy foUowing resection of non — smaU ceU bronchogenic carcinoma. Intern J 
Radia Oncol, Biol, Phys. 20:945-951, 1991. 
Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Rodriguez A, LicciardeUo J, 
Owen-Schaub LB, Hong WK, Roth JA: Clinical and immunomodulatory effects of combina- 
tion immunotherapy with low-dose BL-2 and tumor necrosis factor-alpha in patients with 
advanced non-smaU ceU lung cancer: A phase I trial. Cancer Res 51:3669-3679, 1991. 
Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA: p53 gene mutations in 
premalignant Barrett’s epitheUum. Cancer Res 5 1(1 6): 4495-4499, 1991. 
Yang SC, Grimm EA, Roth JA: Immunotherapy of lung cancer. Chest Surgery CUnics of 
North America 1(1): 191-204, 1991. 
Zatopek NK, Holoye PY, EUerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang 
AC, GUsson BS: ResectabUity of smaU-ceU lung cancer foUowing induction chemotherapy in 
patients with limited disease (stage n-HIb). Am J CUn Oncol 14(5): 427-432, 1991. 
Putnam EA, Yen N, GaUick GE, Steck PA, Fang K, Akpakip B, Gazdar AF, Roth JA: 
Autocrine growth stimulation by transforming growth factor-a in human non-smaU ceU lung 
cancer. J Surg Oncol 1:49-60, 1992. 
Mukhopadhyay T, Roth JA: A simple and efficient method for isolation of DNA fragment 
from agarose gel. J Nucleic Acids Res 19(23):6656, 1992. 
Casson AG, Putnam JB, Natarajan G, Johnston DA, Mountain C, McMurtrey M, Roth HA: 
Five year survival after pulmonary metastases for adult soft tissue sarcoma. Cancer 
69(1):662- 668, 1992. 
Recombinant DNA Research, Volume 19 
[297] 
